Literature DB >> 4004425

Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease. Effect of hemodialysis.

A N Elias, N D Vaziri, M Maksy.   

Abstract

The effect of hemodialysis on plasma norepinephrine (NE), epinephrine, and dopamine levels was studied in 11 patients undergoing maintenance hemodialysis. The results showed that the baseline plasma concentrations of NE and dopamine were significantly elevated in patients with end-stage renal disease undergoing maintenance hemodialysis. Intradialysis weight loss and fall in the serum glucose concentration during dialysis correlated with changes in plasma epinephrine and NE concentrations. Single-pass dialysis resulted in a marked reduction in the plasma NE concentration, indicating significant removal by dialysis. These observations should be taken into consideration when interpreting plasma catecholamine data obtained in the course of investigation of hypertensive patients with end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004425

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses.

Authors:  N J Sarlis; O Caticha; J L Anderson; C Kablitz; F S Shihab
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

Review 2.  The role of the kidney and the sympathetic nervous system in hypertension.

Authors:  Philip Thomas; Indranil Dasgupta
Journal:  Pediatr Nephrol       Date:  2014-03-08       Impact factor: 3.714

3.  Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease.

Authors:  Jeanie Park; Robert H Lyles; Susan Bauer-Wu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-05-14       Impact factor: 3.619

4.  Adrenal Incidentaloma: Challenges in Diagnosing Adrenal Myelolipoma.

Authors:  Sreedhar Adapa; Srikanth Naramala; Vijay Gayam; Frank Gavini; Hemant Dhingra; Florette Kimberly Gray Hazard; Narothama Reddy Aeddula; Venu Madhav Konala
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

5.  Cardiovascular and renal effects of bromocriptine in diabetic patients with stage 4 chronic kidney disease.

Authors:  Oliva Mejía-Rodríguez; Jorge E Herrera-Abarca; Guillermo Ceballos-Reyes; Marcela Avila-Diaz; Carmen Prado-Uribe; Francisco Belio-Caro; Antonio Salinas-González; Helios Vega-Gomez; Cleto Alvarez-Aguilar; Bengt Lindholm; Elvia García-López; Ramón Paniagua
Journal:  Biomed Res Int       Date:  2013-08-04       Impact factor: 3.411

6.  Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.

Authors:  Jeanie Park
Journal:  Cardiol Res Pract       Date:  2012-08-07       Impact factor: 1.866

Review 7.  Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.

Authors:  Jasdeep Kaur; Benjamin E Young; Paul J Fadel
Journal:  Int J Mol Sci       Date:  2017-08-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.